Overview

Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and efficacy of duloxetine for the treatment of social anxiety disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Duloxetine Hydrochloride